ASCEND-2: A single-arm, open-label, multicenter phase II study of ceritinib in adult patients (pts) with ALK-rearranged (ALK plus ) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ)
| Autor: | Tony Mok, Spigel, David, Felip, Enriqueta, Demarinis, Filippo, Ahn, Myung-Ju, Groen, Harry J. M., Wakelee, Heather A., Hida, Toyoaki, Crino, Lucio, Nishio, Makoto, Scagliotti, Giorgio V., Branle, Fabrice, Emeremni, Chetachi, Quadrigli, Massimiliano, Zhang, Jie, Shaw, Alice Tsang |
|---|---|
| Zdroj: | ResearcherID Publons |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|